Table 1.
Demographic and clinical characteristics of study participants at baseline.
| Characteristic | N (%) N=922 |
|---|---|
| Gender | |
| Male | 472 (51.19%) |
| Female | 450 (48.81%) |
| Age at first-line therapy years | 64.79 (9.99) |
| Not reported | 3 (0.33%) |
| Primary tumor Site | |
| Intrahepatic | 461 (50%) |
| Extrahepatic | 204 (22.13%) |
| Gallbladder | 197 (21.37%) |
| Ampullary tumor | 56 (6.07%) |
| Not reported | 4 (0.43%) |
| Disease Status | |
| Locally Advanced | 207 (22.45%) |
| Metastatic | 709 (76.9%) |
| Not reported | 6 (0.65%) |
| Period of first-line therapy | |
| 2000-2009 | 274 (29.72%) |
| 2010-2013 | 374 (40.56%) |
| 2014-2017 | 272 (29.5%) |
| Not reported | 2 (0.22%) |